Ravin Consultants announced today a leadership evolution that reflects the strength of its foundation and its long-term vision for the future of the 340B program. This press release features ...

A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...

This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price. Payers have struggled with the increasing ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have saved patients, taxpayers and employers billions of dollars. But fortunately ...

Add Yahoo as a preferred source to see more of our stories on Google. In a recent opinion piece, it was suggested the federal 340B Drug Pricing Program is contributing to rising employer health-care ...

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a recent 340B transparency report from the Minnesota Department of Health — a ...

(Corrects paragraph 8 to clarify the potential impact of AbbVie's lawsuit.) April 8 (Reuters) - AbbVie has filed a lawsuit ...

The 340B Drug Pricing Program allows certain medical facilities to buy drugs at a discount to support care for low-income patients. Rhode Island's new law, Chapter 288, prevents drug makers from ...

The 340B Drug Pricing Program was originally constructed so safety-net health care facilities could stretch scarce resources in caring for low-income patients. However, the program has experienced ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.